Skip to main content

Table 2 Initial laboratory data, disease course, and follow-up for individual patients

From: Urinary β2-microglobulin and disease activity in patients with tubulointerstitial nephritis and uveitis syndrome

Patient

Age/sex

Uveitis location

Laboratory data

Renal biopsy

Mandeville criteria

Oral steroids

Follow-up (months)

Disease duration (months)

Remission

ANA

ANCA

ACE

HLA-B27

RF

Lyme

Syphilis

Initial Uβ2M (μg/L)

Elevated SCr

UA protein

1

12/M

A

2557

+

+

+

D

+

74

51.5

+

2

14/M

A

+

N

6745

+

+

D

+

7.7

7.7

3

15/M

A

1711

P

+

41.4

18

+

4

16/M

A

3093

P

+

26.3

26.3

5

18/F

P

N

N

3169

+

+

P

+

28.1

13.3

+

6

42/F

I

N

13,669

+

+

+

D

+

17

17

7

53/F

A

 

N

17,494

+

++

D

+

72.4

31.3

+

8

64/F

A

N

N

N

833

+

P

2.5

2.5

9

67/F

I

9557

+

+

P

+

59.8

46.7

+

  1. ANA antinuclear antibody, ANCA antineutrophil antibody, ACE angiotensin-converting enzyme, RF rheumatoid factor, Uβ2M urine β-2 microglobulin, SCr serum creatinine, UA urinalysis, F female, M male, A anterior uveitis, I intermediate uveitis, P panuveitis, N not performed, D definite, P probable; + = trace protein on UA; ++ = 1+ protein on UA